This research aimed to evaluate bioavailability and compare pharmacokinetic ( PK ) properties of the new SR paracetamol formulation ( 2x1 ,000 mg ) with those of immediate-release ( IR ) paracetamol ( 2x500 mg ) and existing extended-release ( ER ) paracetamol ( 2x665 mg ) .